CompoAtlas

Jamp-K-Citrate 10 Solution

Natural health product licensed in Canada

Licence holder
JAMP Pharma Corporation
NPN or DIN-HM
80062300
Status
Active licence
Licence date
29 June 2015
Revision date
Not provided
Form
Liquide oral, solution
Route of administration
Orale
Application type
TPD Cat IV/LS

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sel de tripotassium d'acide 2-hydroxy-1,2,3-propanétricarboxylique

Source : Citrate de potassium monohydraté

Potency : 0 10 mEq Potassium

Not specifiedNot calculated
Sel de tripotassium d'acide 2-hydroxy-1,2,3-propanétricarboxylique

Source : Citrate de potassium monohydraté

Potency : 390 milligramme Potassium

1,080 milligrammeNot calculated

Non-medicinal ingredients

Acide citrique, FD&C Red no 3, Eau purifiée, Acesulfame-K, Longan berry flavor, Glycérine, Saveur de vanille, Sorbate de potassium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Treatment or prevention of hypokalemia (potassium depletion) which does not result from dietary deficiency.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80062300

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line